Article Versions Notes

Goseki T, Mochizuki Y, Masuda A, Kiyosawa M, Miyamoto R, Wakakura M, Yamagami A, Mukai Y, Shinkai A, Iijima M, et al. Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan. Toxins. 2026; 18(2):109. https://doi.org/10.3390/toxins18020109

Goseki, Toshiaki, Yoshihito Mochizuki, Akiko Masuda, Motohiro Kiyosawa, Ryosuke Miyamoto, Masato Wakakura, Akiko Yamagami, Yohei Mukai, Akihiro Shinkai, Mutsumi Iijima, and et al. 2026. "Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan" Toxins 18, no. 2: 109. https://doi.org/10.3390/toxins18020109

Goseki, T., Mochizuki, Y., Masuda, A., Kiyosawa, M., Miyamoto, R., Wakakura, M., Yamagami, A., Mukai, Y., Shinkai, A., Iijima, M., Baba, K., Chuman, H., Hashizuka, M., Tateishi, S., & Kimura, A. (2026). Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan. Toxins, 18(2), 109. https://doi.org/10.3390/toxins18020109